Coherus BioSciences

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.

About CHRS

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE.

CEO

Denny M. Lanfear

CEODenny M. Lanfear

Employees

332

Employees332

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2010

Founded2010

Employees

332

Employees332

CHRS Key Statistics

Market cap

529.67M

Market cap529.67M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

686.88K

Average volume686.88K

High today

$6.81

High today$6.81

Low today

$6.55

Low today$6.55

Open price

$6.70

Open price$6.70

Volume

847.85K

Volume847.85K

52 Week high

$18.38

52 Week high$18.38

52 Week low

$5.60

52 Week low$5.60

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

37.5%

Sell

CHRS Earnings

-$1.00

-$0.65

-$0.29

$0.06

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Feb 16, After Hours

ActualExpected Feb 16, After Hours